Gliflozins in the Management of Cardiovascular Disease

Gliflozins in Cardiac and Renal DiseaseGliflozins - sodium-glucose cotransporter 2 inhibitors - lower blood glucose and glycated hemoglobin in patients with type 2 diabetes without causing hypoglycemia. The agents also improve cardiac function in patients who have heart failure with or without type 2 diabetes and improve renal function, with few adverse effects.

Automated summary

Gliflozins, a type of medication used to treat type 2 diabetes, not only lowers blood glucose levels but also improves cardiac and renal function.